top of page

State of Possible: Laurel Biotherapeutics is a startup that is developing antibodies for cardiovascular disease - they are already benefiting from the support that the Boston area offers

  • Mar 26
  • 1 min read

Co-Founders Matthew Therkelsen and Tatiana Blanchard describe the work that Laurel is doing and some of the support they have received as they launch the company, such as help with lab space.



 
 

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page